Use of OnabotulinumtoxinA in Post-Traumatic Oromandibular Dystonia

Pedemonte, Christian; Gutiérrez, Hernán Pérez; González, Edgardo; Vargas, Ilich; Lazo, Diego

doi:10.1016/j.joms.2014.07.027

Cited by 14 publications

(5 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…If bruxism is a type of dystonia, it is possible that the success of the most common treatment of bruxism, with intraoral appliances or occlusal adjustments, may simply be a ‘‘sensory trick’’ that relieves dystonicsymptoms. Regardless of the etiology of bruxism, successful use of Botulinum Toxin for bruxism has been described ( 10 - 13 ).…”

Section: Introductionmentioning

confidence: 99%

Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study

Alwayli¹

2016

J Clin Exp Dent

View full text Add to dashboard Cite

BackgroundTo evaluate the role of botulinum toxin type A (BTX-A) in the treatment of pain associated with nocturnal bruxism.Material and MethodsFifty subjects reporting nocturnal bruxism were recruited for a randomized clinical trial. Twenty five bruxers were injected with botulinum toxin in both masseters, and twenty five were treated with traditional methods of treating bruxism. Patients were evaluated at 3rd week, 2nd and 6th month and one year after injection and then used to calculate bruxism events. Bruxism symptoms were investigated using questionnaires.ResultsMean pain score due to Bruxism events in the masseter muscle decreased significantly in the botulinum toxin injection group A (P =0.000, highly significant). However, in the conventional treatment group, mean pain score does not show improvement with time (p>0.05).ConclusionsOur results suggest that botulinum toxin injection reduced the mean pain score and number of bruxism events, most likely by decreasing the muscle activity of masseter rather than affecting the central nervous system. Key words:Temporomandibular pain, nocturnal bruxism, botulinum toxin.

show abstract

Section: Introductionmentioning

confidence: 99%

Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study

Alwayli¹

2016

J Clin Exp Dent

View full text Add to dashboard Cite

show abstract

“…Out of 12 studies included for final review following data were extracted: author, publication year, number of cases reported, age, gender, clinical features, treatment summary and outcome (Table 1). 4,7,[9][10][11][12][13][14][15][16][17] The data was tabulated and the results recorded. Total of 89 patients with OMD were reported in 12 articles.…”

Section: Resultsmentioning

confidence: 99%

Oromandibular Dystonia: An Update for Dental Professionals

Hegde

Ajila

2022

Cumhuriyet Dental Journal

View full text Add to dashboard Cite

Oromandibular Dystonia (OMD) is a type of focal dystonia which affects the masticatory, cervical, facial, eyelid, laryngeal, and pharyngeal muscles. OMD patients may consult dentists with involuntary movement or spasm of the lips, tongue, involuntary jaw opening or closing, changes in the occlusion, slurred speech, drooling of saliva, difficulty in mastication, swallowing, and speaking. Due to the uncommon occurrence of OMD, this condition may be misdiagnosed and may lead to unnecessary treatment. Thus thorough knowledge regarding the features of OMD is essential for the dentists. Present review focus on the signs and symptoms of OMD, diagnosis and management of these patients.

show abstract

“…Post-traumatic oromandibular dystonia [69], often associated with bruxism, occurs after TBI. Furthermore, it has been shown that bruxism contributes not only to post-TBI headaches [70] but is also correlated with the presence of tinnitus [71].…”

Section: Oralmentioning

confidence: 99%

From Provider to Advocate: The Complexities of Mild Traumatic Brain Injury Prompt the Evolution of Provider Engagement

Singman¹

2021

Preprint

View full text Add to dashboard Cite

Treating a patient with traumatic brain injury requires an interdisciplinary approach because of the pervasive, profound and protean manifestations of this condition. In this review, key aspects of the medical history and review of systems will be described in order to highlight how the role of any provider must evolve to become a better patient advocate. Although this review is written from the vantage point of a vision care provider, it is hoped that patients, caregivers and providers will recognize the need for the team approach; it truly takes a village.

show abstract

Use of OnabotulinumtoxinA in Post-Traumatic Oromandibular Dystonia

Cited by 14 publications

References 21 publications

Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study

Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study

Oromandibular Dystonia: An Update for Dental Professionals

From Provider to Advocate: The Complexities of Mild Traumatic Brain Injury Prompt the Evolution of Provider Engagement

Contact Info

Product

Resources

About